Brain Tumor FAQs
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

  • Question: What is Gliadel® Wafer?
  • Answer:08/23/2004
    GLIADEL® Wafer delivers BCNU directly to the site of the recurrent brain tumor.

    After a surgeon operates to remove GBM tissue, he or she implants up to eight dime-sized GLIADEL® Wafers in the space the tumor once occupied. Each wafer contains a precise amount of BCNU. Over the next 2 to 3 weeks, the wafers slowly dissolve, bathing the surrounding cells with BCNU. The goal of GLIADEL® Wafer therapy is to kill tumor cells left behind after surgery, thereby extending survival. (This was taken from the gliadel.com website with permission
DISCLAIMER
This site is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided at this web site is of a general nature and is not intended to take the place of a physician's advice. We encourage individuals to discuss what they find on this site with their healthcare providers. The answer above was provided by a volunteer, based solely on their experiances and thoughts. These volunteers do not get paid and are not responsible for the accuracy of their responses. IF you disagree with a response, let us know and we will look into it.


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites